Show simple item record

dc.contributor.authorFoeldvari, Ivan
dc.contributor.authorBohn, Marcela
dc.contributor.authorPetrushkin, Harry
dc.contributor.authorHan, S. Angeles
dc.contributor.authorBangsgaard, Regitze
dc.contributor.authorCalzada-Hernández, Joan
dc.contributor.authorConstantin, Tamas
dc.contributor.authorde Boer, Joke H.
dc.contributor.authorDíaz-Cascajosa, Jesus
dc.contributor.authorEdelsten, Clive
dc.contributor.authorGlerup, Mia
dc.contributor.authorIngels, Helene
dc.contributor.authorKramer, Sebastian
dc.contributor.authorMiserocchi, Elisabetta
dc.contributor.authorNordal, Ellen Berit
dc.contributor.authorSaurenmann, Rotraud K.
dc.contributor.authorSimonini, Gabriele
dc.contributor.authorSolebo, Ameenat Lola
dc.contributor.authorTitz, Jan
dc.contributor.authorAnton, Jordi
dc.date.accessioned2025-02-27T13:45:15Z
dc.date.available2025-02-27T13:45:15Z
dc.date.issued2024-04-04
dc.description.abstractBackground - Juvenile idiopathic arthritis (JIA)-associated uveitis typically presents as a silent chronic anterior uveitis and can lead to blindness. Adherence to current screening guidelines is hampered by complex protocols which rely on the knowledge of specific JIA characteristics. The Multinational Interdisciplinary Working Group for Uveitis in Childhood identified the need to simplify screening to enable local eye care professionals (ECPs), who carry the main burden, to screen children with JIA appropriately and with confidence. <p> <p>Methods - A consensus meeting took place in January 2023 in Barcelona, Spain, with an expert panel of 10 paediatric rheumatologists and 5 ophthalmologists with expertise in paediatric uveitis. A summary of the current evidence for JIA screening was presented. A nominal group technique was used to reach consensus. <p> <p>Results - The need for a practical but safe approach that allows early uveitis detection was identified by the panel. Three screening recommendations were proposed and approved by the voting members. They represent a standardised approach to JIA screening taking into account the patient’s age at the onset of JIA to determine the screening interval until adulthood. <p> <p>Conclusion - By removing the need for the knowledge of JIA categories, antinuclear antibody positivity or treatment status, the recommendations can be more easily implemented by local ECP, where limited information is available. It would improve the standard of care on the local level significantly. The proposed protocol is less tailored to the individual than the ‘gold standard’ ones it references and does not aim to substitute those where they are being used with confidence.en_US
dc.identifier.citationFoeldvari, Bohn, Petrushkin, Han, Bangsgaard, Calzada-Hernández, Constantin, de Boer, Díaz-Cascajosa, Edelsten, Glerup, Ingels, Kramer, Miserocchi, Nordal, Saurenmann, Simonini, Solebo, Titz, Anton. A practical approach to uveitis screening in children with juvenile idiopathic arthritis. British Journal of Ophthalmology. 2024en_US
dc.identifier.cristinIDFRIDAID 2264185
dc.identifier.doi10.1136/bjo-2023-324406
dc.identifier.issn0007-1161
dc.identifier.issn1468-2079
dc.identifier.urihttps://hdl.handle.net/10037/36592
dc.language.isoengen_US
dc.publisherBMJ Publishing Groupen_US
dc.relation.journalBritish Journal of Ophthalmology
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2024 The Author(s)en_US
dc.titleA practical approach to uveitis screening in children with juvenile idiopathic arthritisen_US
dc.type.versionacceptedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


File(s) in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record